Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
(se abrirá en una nueva ventana)
Autores:
Ervin Ascic, Gaia Fontanari, Maria Thrasyvoulou, César Pérez Bucio, Tommaso Ballocci, Carlos-Filipe Pereira
Publicado en:
Journal of Visualized Experiments, 2025, ISSN 1940-087X
Editor:
MyJove Corporation
DOI:
10.3791/68739
Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity
(se abrirá en una nueva ventana)
Autores:
Luís Henriques-Oliveira, Abigail R. Altman, Ilia Kurochkin, Ervin Ascic, Evelyn Halitzki, Andreea-Medeea Matei, Diogo Pértiga-Cabral, Isabel Ulmert, Signe Holst, Malavika Sreekumar Nair, Pedro P. Cunha, Sun-Mi Park, Stefano Vergani, Michael G. Kharas, Joan Yuan, Katharina Lahl, Fábio F. Rosa, Cristiana F. Pires, Carlos-Filipe Pereira
Publicado en:
Immunity, Edición 58, 2026, ISSN 1074-7613
Editor:
Elsevier BV
DOI:
10.1016/J.IMMUNI.2025.08.001
A combinatorial transcription factor screening platform for immune cell reprogramming
(se abrirá en una nueva ventana)
Autores:
Ilia Kurochkin, Abigail R. Altman, Inês Caiado, Diogo Pértiga-Cabral, Evelyn Halitzki, Mariia Minaeva, Olga Zimmermannová, Luís Henriques-Oliveira, Dominik Klein, Malavika Nair, Daniel Oliveira, Laura Rabanal Cajal, Ramin Knittel, Cora Feick, Markus Ringnér, Marcel Martin, Branko Cirovic, Cristiana F. Pires, Fabio F. Rosa, Ewa Sitnicka, Fabian J. Theis, Carlos-Filipe Pereira
Publicado en:
Cell Systems, Edición 17, 2026, ISSN 2405-4712
Editor:
Elsevier BV
DOI:
10.1016/J.CELS.2025.101457
